# Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes

> **NCT02048189** · PHASE4 · TERMINATED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 14 (actual)

## Conditions studied

- Patient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy

## Interventions

- **DRUG:** LEVEMIR
- **DRUG:** APIDRA

## Key facts

- **NCT ID:** NCT02048189
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03-08
- **Primary completion:** 2015-02-26
- **Final completion:** —
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** recruitment difficulties
- **Last updated:** 2024-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048189, "Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02048189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*